— Know what they know.
Not Investment Advice

STLNW NASDAQ

Starling Oncology Inc. Wt
1W: -2.0% 1M: -41.9% YTD: -20.4%
$0.04
-0.01 (-20.45%)
 
Weekly Expected Move ±62.5%
$-0 $0 $0 $0 $0
NASDAQ · Healthcare · Medical - Care Facilities · Tech Score Strong Sell · Power 37 · $3.9M mcap · 63M float · 0.0008% daily turnover · Short 46% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$3.9M
52W Range0.0202-0.069
Volume2,058
Avg Volume500
Beta2.64
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEODaniel Virnich
Employees641
SectorHealthcare
IndustryMedical - Care Facilities
IPO Date2026-08-04
18000 Studebaker Road, Suite 800
Cerritos, CA 90703
US
About Starling Oncology Inc. Wt

The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms